Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2021
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Amod A Sarnaik, Omid Hamid, Nikhil I Khushalani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Science Translational Medicine
|
November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2021
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Amod A Sarnaik, Omid Hamid, Nikhil I Khushalani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Science Translational Medicine
|
November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 6